Os dispositivos de pressao positiva autoajustavel na via aerea (autoCPAP,
autoPAP, APAP) foram desenvolvidos com duas finalidades:
Nowadays, there are several instruments which have been used to screen for abnormal cervical cells such as semi-automated or interactive system (PAPNET) and automated systems (
AutoPap 300, FocalPoint, and ThinPrep Imaging System (TIS)) [30, 33, 39-41].
*
AutoPap: a fully automated computerized quality control system that rescreens all Pap test slides for fewer false-negative results--when tests fail to detect existing abnormalities.
The
AutoPap System for primary screening in cervical cytology: comparing the results of a prospective, intended-use study with routine manual practice.
AutoPap 300 QC Automatic Pap Screener System: a fully automated quality control system that re-screens all Pap smear slides for fewer false-negative results--when tests fail to detect existing abnormalities.
Detection of high grade squamous intraepithelial lesions and tumors using the
AutoPap system: results of a primary screening clinical trial.
Newer technologies including thin-layer cytology (Thin-Prep), computerized re-screening (Papnet), and algorithmic classification (
AutoPap) of slides can increase the sensitivity of cervical cancer screening by up to 30% at an increased cost of $5 to $10 per slide.
The
AutoPap software uses an image recognition system and rates Pap smears according to normalcy.
In recent years, two computerized Pap smear screening technologies have been introduced--
AutoPap and Papnet.
The
AutoPap and Papnet systems were approved by the FDA in the latter half of 1995.